NR4A1 and breast cancer: Higher expression of plasma hsa-miR-100-5p was present in BC patients with hormone receptor positivity and metastasis after dovitinib treatment, and the circulating hsa-miRNA-100-5p levels were able to separate patients with resistant disease from sensitive patients [31].